Preparation for the impending epidemic of the COVID-19 coronavirus is of utmost importance. The first rule of infection prevention is that the infection preventionist (IP) does not become infected.
Regulatory and public health agencies in the US provide clear guidance on what products may be used in outbreaks of emerging pathogens.
About 20% of passengers in an airport have clean hands. If that increases to 30%, a potential infectious disease would have a worldwide impact that is about 24% smaller.
Seqirus announced today that the US Food and Drug Administration (FDA) has approved Fluad Quadrivalent, touted as the first and only adjuvanted quadrivalent influenza vaccine, developed to help protect adults 65 years and older against seasonal influenza.
Christina Tan, MD, MPH, state epidemiologist and assistant commissioner with the New Jersey Department of Health, discusses the current coronavirus outbreak and how infection prevention efforts can help curb its spread.